FHL3 and pancreatic neoplasm: We found weaker metastatic ability in pancreatic cancer cells (PANC1_KD1 and BXPC3_KD1 cells), both in vitro and in vivo experiments, after FHL3 knockdown (Figure 3C, 3D; Figure 6F1-2).